La. Admin. Code tit. 46 § LXXXV-704

Current through Register Vol. 50, No. 11, November 20, 2024
Section LXXXV-704 - Consulting and Providing Legend and Certain Controlled Substances
A. Legend Drugs
1. When an animal control agency which is operated by a state or local governmental agency or which is operated by any duly incorporated humane society which has a contract with a local governmental agency to perform animal control services on behalf of the local governmental agency seeks to administer legend drugs to an animal for the sole purpose of animal capture and/or animal restraint, the animal control agency must have a staff or consulting veterinarian who is licensed to practice veterinary medicine by the Board of Veterinary Medicine and who obtains the legend drugs.
2. Said legend drugs must be stored and administered under the general supervision of the licensed veterinarian. General supervision means that the licensed veterinarian must provide the employee(s) of the animal control agency with written instructions and follow-up assistance on the proper storage, use and administration of the drug(s) being provided.
3. The licensed veterinarian may submit to the board, for review and/or approval, a written protocol of his supervision of the animal control agency's employees.
4. The licensed veterinarian shall also require the animal control agency's employees to maintain record keeping logs which shall include, but would not be limited to, the following:
a. date of each use of a legend drug;
b. species of animal;
c. estimated weight of animal;
d. dose administered;
e. name of animal control officer administering the drug.
5. Said records should be reviewed by the supervising veterinarian on at least a quarterly basis.
B. Telazol (Tiletamine HCl and Zolazepam HCl) and Ketamine (Ketamine HCl)
1. When an animal control agency which is operated by a state or local governmental agency or which is operated by any duly incorporated humane society which has a contract with a local government agency to perform animal control services on behalf of the local governmental agency seeks to administer the controlled substance Telazol (tiletamine HCl and zolazepam HCl) or Ketamine (ketamine HCl), to an animal for the sole purpose of animal capture and/or animal restraint, the animal control agency, unless it has a Lead CAET as defined in R.S. 37:1552(4), must have a staff or consulting veterinarian who is licensed to practice veterinary medicine by the Board of Veterinary Medicine and who is registered with the Drug Enforcement Administration (DEA) and licensed by the state controlled dangerous substances program at the shelter location where the drugs will be stored and administered who obtains, and who is responsible for, the Telazol (tiletamine HCl and zolazepam HCl) or Ketamine (ketamine HCl) used.
2. A storage and use plan for Telazol (tiletamine HCl and zolazepam HCl) and Ketamine (ketamine HCl) which meets or exceeds the requirements of all federal or state drug enforcement agencies (including storage of controlled substances in a securely locked, substantially constructed cabinet and the keeping of a perpetual inventory as required by LAC 48:I.Chapter 39) and the record keeping requirements of this Chapter shall be submitted to the Board of Veterinary Medicine for approval.
a. This usage plan shall include a requirement that each use of Telazol (tiletamine HCl and zolazepam HCl) and Ketamine (ketamine HCl) shall be documented for review by the licensed veterinarian responsible for the purchase and inventory of that drug.
b. This usage plan shall include a requirement that this documentation include, but not be limited to:
i. date of each use of the drug;
ii. species of animal;
iii. estimated weight of animal;
iv. dose administered;
v. name of animal control officer administering the drug;
vi. a constant (running) inventory of the drug present at the facility.
c. This usage plan shall include a requirement that a review of each use of Telazol (tiletamine HCl and zolazepam HCl) and Ketamine (ketamine HCl) shall be made by the responsible veterinarian and that said veterinarian shall initial the usage log entries to indicate this review. A review of the usage plan shall be made at least quarterly and the quantities of the drug used and on hand shall be tallied and authenticated. Any variance shall be noted in the log and steps should be taken and documented to correct the problem.
d. This usage plan shall include a requirement that any removal of Telazol (tiletamine HCl and zolazepam HCl) or Ketamine (ketamine HCl) from the securely locked, substantially constructed cabinet shall be in minimal amounts, shall be maintained in a locked container when not in use, and shall be documented in a manner to include, but not be limited to:
i. a signed log indicating the person removing the drug;
ii. the date on which the drug was removed;
iii. an accounting for all drug used and the amount returned;
iv. the date on which the remaining drug was returned and the signature of the person returning it.
C. A licensed veterinarian who chooses to assist an animal control shelter in the methods prescribed in §704 shall be solely responsible for which drugs he or she is willing to provide and in what quantities.
D.Section 704 does not pertain to any controlled substances listed in any DEA classification schedule or state of Louisiana classification schedule, except Telazol (tiletamine HCl and zolazepam HCl) and Ketamine (ketamine HCl). This Section specifically does not apply to sodium pentobarbital, which is regulated for animal control agency use in R.S. 37:1551-1558.
E. The definitions found in §700 shall apply to all terms used in §704
F. Failure of a licensed veterinarian to comply with any and all provisions of §704 shall be considered a violation of the rules of professional conduct. Said veterinarian may be subject to disciplinary action as provided for in R.S. 37:1518 and 1526.

La. Admin. Code tit. 46, § LXXXV-704

Promulgated by the Department of Health and Hospitals, Board of Veterinary Medicine, LR 20:666 (June 1994); amended LR 24:334 (February 1998), LR 25:519 (March 1999), LR 26:317 (February 2000).
AUTHORITY NOTE: Promulgated in accordance with R.S. 37:1518.